Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04487587
Title A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer (COMICE)
Acronym COMICE
Recruitment Unknown status
Gender female
Phase Phase II
Variant Requirements No
Sponsors The Clatterbridge Cancer Centre NHS Foundation Trust
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR


No variant requirements are available.